Medicine and Dentistry
Premature Labor
100%
Disease
95%
Ovarian Cancer
91%
Neoplasm
90%
Endometrial Cancer
89%
Cesarean Section
79%
Malignant Neoplasm
76%
Pregnancy
71%
Gynecological Oncology
56%
Odds Ratio
55%
Cervical Cancer
44%
Pelvis
41%
Pre-Eclampsia
39%
Overall Survival
37%
Oncology
37%
Obstetrics
36%
Krukenberg Tumor
33%
Gestational Age
33%
Human Immunodeficiency Virus
33%
Infection
32%
Recurrent Disease
31%
Placenta
31%
Colposcopy
31%
First Trimester Pregnancy
30%
Systematic Review
30%
Randomized Controlled Trial
29%
Cancer
29%
Endometrium Carcinoma
28%
Body Mass Index
28%
Oocyte
28%
Health Care Cost
28%
Childbirth
28%
Wart Virus
27%
Symptom
27%
Meta-Analysis
27%
Retrospective Cohort Study
26%
Fetus Growth
26%
Vaginal Delivery
25%
Amnion Fluid
25%
Endometriosis
24%
Logistic Regression Analysis
24%
Vaginal Birth after Cesarean
23%
Bladder
23%
Radiation Therapy
22%
Progression Free Survival
22%
Hysterectomy
21%
Neonate
21%
Small for Gestational Age
20%
Carcinoma
20%
Surgery
20%
Newborn Morbidity
20%
Cervix
20%
Metastatic Carcinoma
20%
In Vitro Fertilisation
20%
Cytotechnology
20%
Intrauterine Growth Retardation
19%
Biopsy
19%
Birth Weight
19%
Second Trimester Pregnancy
18%
Clinician
18%
Female Genital Tract Cancer
17%
Cervical Intraepithelial Neoplasia
17%
Bleeding
17%
Programmed Cell Death
17%
Epileptic Absence
17%
Diagnosis
16%
Paclitaxel
16%
Magnetic Resonance Imaging
16%
Counseling
16%
Intrapartum
16%
Gynecology
16%
Assisted Reproductive Technology
16%
Prevalence
15%
Hazard Ratio
15%
Papanicolaou Stain
15%
Cancer Cell
15%
Maternal Morbidity
15%
Intrauterine Device
15%
Endometrium
15%
Injury
15%
Clinical Trial
15%
Biological Marker
15%
Umbilical Artery
15%
Pelvic Organ Prolapse
14%
Prematurity
14%
In Vitro
14%
Blastocyst
14%
Chorioamnionitis
14%
Stillbirth
14%
Cervical Cancer Screening
14%
Echography
14%
Microsatellite Instability
13%
Fetus Monitoring
13%
Nulliparous
13%
Twin Pregnancy
13%
Urinary Tract Infection
13%
Pelvic Floor
13%
Twin Twin Transfusion Syndrome
13%
Cytokine
13%
Fallopian Tube
13%
Keyphrases
Confidence Interval
95%
Endometrial Cancer
78%
Ovarian Cancer
71%
Tumor
59%
Preterm Birth
55%
Fetus
52%
Preterm Labor
49%
Cervical Cancer
44%
Cesarean Delivery
44%
Pregnant Women
41%
Preeclampsia
41%
Gynecologic Oncology Group
39%
Overall Survival
37%
Placenta
35%
NRG Oncology
35%
Risk Factors
32%
United States
30%
Extravillous Trophoblast
29%
During Pregnancy
29%
Colposcopy
29%
Randomized Controlled Trial
29%
Endometriosis
29%
Gestational Age
28%
Obesity
28%
Adjusted Odds Ratio
28%
Group Studies
28%
Adverse Pregnancy Outcomes
28%
Chemotherapy
27%
Amniotic Fluid
27%
High Risk
27%
Odds Ratio
26%
Meta-analysis
24%
Retrospective Cohort Study
24%
Vaginal Birth
24%
Apoptosis
24%
Trophoblast
24%
Neonatal Morbidity
23%
Infertility
23%
Endometrial Carcinoma
22%
Spontaneous Preterm Birth (sPTB)
22%
Body Mass Index
22%
Neonatal Outcome
22%
First Trimester
21%
Pregnancy Outcome
21%
AIDS/HIV
21%
Ultrasound
21%
Preterm Delivery
20%
Systematic Meta-analysis
20%
Small-for-gestational Age
20%
Long-acting Reversible Contraception
20%
High-risk Human Papillomavirus (HR-HPV)
20%
Progression-free Survival
20%
Whole Genome
19%
Selective Intrauterine Growth Restriction (sIUGR)
19%
Hysterectomy
19%
Gynecologic Oncology
19%
In Vitro Fertilization
19%
Uterus
19%
Obstetrics and Gynaecology
19%
Cervical Intraepithelial Neoplasia
18%
Cisplatin
18%
Cervical Carcinoma
17%
Week of Gestation
17%
Ovarian Cancer Patients
17%
Epithelial Ovarian Cancer
17%
Neonate
17%
Hazard Ratio
17%
Induction of Labor
17%
Twin-twin Transfusion Syndrome
17%
Pan-cancer Analysis
17%
Fetal Growth Restriction
17%
Relative Risk
17%
Ovarian Cancer Cells
16%
Contraceptives
16%
Inflammation
16%
Intrauterine Inflammation
16%
Paclitaxel
16%
Obese Women
16%
Microsatellite Instability-high (MSI-H)
16%
Cervical Cancer Screening
16%
Second Trimester
15%
Singleton Pregnancy
15%
Human Placenta
15%
Birth Weight
15%
Intra-amniotic Infection
15%
Vaginal Delivery
15%
Endometrial Stromal Cells
15%
Radiation Therapy
14%
Randomized Trial
14%
Gynecologic Malignancies
14%
Glucose Transporter 1 (GLUT1)
14%
Gene Expression
14%
Gynecological Cancer
14%
Bevacizumab
14%
Adverse Neonatal Outcome
14%
Preterm Premature Rupture of Membranes (PPROM)
14%
Urinary Tract Infection
14%
Hypoxia
14%
Progesterone
14%
Bladder
13%